Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures
Year: 2019
Type: article
Source: Annals of the Rheumatic Diseases
Authors: Shervin Assassi, Xuan Wang, Guocai Chen, Ellen Goldmuntz, Lynette Keyes-Elstein, Jun Ying, Paul K Wallace, Jacob Turner, W Jim Zheng, Virginia Pascual, John Varga, Monique E Hinchcliff, Chiara Bellocchi, Peter McSweeney, Daniel E Furst, Richard A Nash, Leslie J Crofford, Beverly Welch, Ashley Pinckney, Maureen D Mayes, Keith M Sullivan
Institutions: The University of Texas Health Science Center at Houston, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Rho (United States), Roswell Park Comprehensive Cancer Center, Stephen F. Austin State University, Weill Cornell Medicine, Northwestern University, Yale University, Colorado Blood Cancer Institute, University of California, Los Angeles, University of Washington, Vanderbilt University, Duke University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Center for Clinical and Translational Sciences (CCTS), Center for Clinical and Translational Sciences (CCTS), G3202541530, Rheumatic Diseases Research Core Centers, Stem Cell Transplantation for Treatment of Autoimmune Diseases, CFlm25 mediated alternative polyadenylation regulates fibrosis in systemic sclerosis, G688778501, Rho Federal Systems Division, Inc. NIAID DAIT SACCC, Institutional Career Development Core
OpenAlex ID: W2965774664